Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease - Summary - MDSpire

Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

  • By

  • Dominik Roth

  • Miriam M Düll

  • Ludwig J Horst

  • Aylin Lindemann

  • Xenia Malzer

  • Kristina Koop

  • Sebastian Zundler

  • Marcel Vetter

  • André Jefremow

  • Raja Atreya

  • Carol Geppert

  • Sören Weidemann

  • Maximilian J Waldner

  • Peter Dietrich

  • Claudia Günther

  • Luis E Munoz

  • Martin Herrmann

  • Alexander Scheffold

  • Markus F Neurath

  • Jürgen Siebler

  • Christoph Schramm

  • Andreas E Kremer

  • Moritz Leppkes

  • August 30, 2024

  • 0 min

Share

Objective:

To investigate the presence of anti-integrin αVβ6 autoantibodies in primary sclerosing cholangitis (PSC) and its association with inflammatory bowel disease (IBD) and other cholestatic liver diseases, including primary biliary cholangitis and autoimmune hepatitis.

Key Findings:
  • Anti-αVβ6 was found in 91% of ulcerative colitis (UC) patients (N=36), 17% of Crohn’s disease (CD) patients (N=65), and 73% of PSC-IBD patients (N=41).
  • 39% of PSC patients (N=18) without IBD also tested positive for anti-αVβ6.
  • The presence of anti-αVβ6 correlated moderately with intestinal disease activity in PSC-IBD.
Interpretation:

Integrin αVβ6 is a significant autoantigen in PSC and IBD, particularly UC, and may play a role in disease pathogenesis and activity.

Limitations:
  • The study was conducted in a limited geographic area (Germany), which may affect generalizability and introduce selection bias.
  • The sample size for some disease groups was relatively small, limiting the statistical power of the findings.
Conclusion:

Anti-αVβ6 autoantibodies are prevalent in PSC, especially in patients with concurrent IBD, suggesting their potential role in disease monitoring and understanding pathogenesis, warranting further investigation.

Original Source(s)

Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

  • by Dominik Roth, Miriam M Düll, Ludwig J Horst, Aylin Lindemann, Xenia Malzer, Kristina Koop, Sebastian Zundler, Marcel Vetter, André Jefremow, Raja Atreya, Carol Geppert, Sören Weidemann, Maximilian J Waldner, Peter Dietrich, Claudia Günther, Luis E Munoz, Martin Herrmann, Alexander Scheffold, Markus F Neurath, Jürgen Siebler, Christoph Schramm, Andreas E Kremer, Moritz Leppkes

  • August 30, 2024

Related Content

GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity

Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease

Color Vision Tied to Bladder Survival

Patients with impaired color perception may be less likely to recognize blood in urine, potentially delaying diagnosis of cancers that rely on visible bleeding as an early warning sign.